InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Viking Therapeutics, Inc.

VKTX Clue Score32
United States Fiscal year ends December CIK 0001607678 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

44
Insider
Date
Role
Action
Shares
Price
Amount
Marianna Mancini
29 Jul 2026
Chief Operating Officer
Sell
18,217
$33.47
$609.64K
Greg Zante
29 Jul 2026
Chief Financial Officer
Sell
21,217
$33.47
$710.14K
Brian Lian
29 Jul 2026
President & CEO
Sell
148,517
$33.32
$4.95M
Brian Lian
5 Jan 2026
President & CEO
Sell
6,400
$35.07
$224.42K
Brian Lian
5 Jan 2026
President & CEO
Sell
41,276
$34.22
$1.41M
Brian Lian
5 Jan 2026
President & CEO
Sell
53,279
$33.38
$1.78M
Brian Lian
5 Jan 2026
President & CEO
Sell
132,454
$32.29
$4.28M
Marianna Mancini
5 Jan 2026
Chief Operating Officer
Sell
1,600
$35.07
$56.12K
Marianna Mancini
5 Jan 2026
Chief Operating Officer
Sell
10,500
$34.22
$359.30K
Marianna Mancini
5 Jan 2026
Chief Operating Officer
Sell
13,600
$33.37
$453.88K
Marianna Mancini
5 Jan 2026
Chief Operating Officer
Sell
31,961
$32.29
$1.03M
Greg Zante
5 Jan 2026
Chief Financial Officer
Sell
1,500
$32.09
$48.13K
Greg Zante
5 Jan 2026
Chief Financial Officer
Sell
10,300
$34.24
$352.63K
Greg Zante
5 Jan 2026
Chief Financial Officer
Sell
13,900
$33.38
$464.02K
Greg Zante
5 Jan 2026
Chief Financial Officer
Sell
31,961
$32.30
$1.03M
Greg Zante
28 Oct 2025
Chief Financial Officer
Sell
6,185
$35.00
$216.48K
Brian Lian
28 Oct 2025
President & CEO
Sell
38,989
$35.01
$1.36M
Marianna Mancini
28 Oct 2025
Chief Operating Officer
Sell
6,185
$35.00
$216.49K
Marianna Mancini
3 Jul 2025
Chief Operating Officer
Sell
4,266
$27.77
$118.47K
Greg Zante
3 Jul 2025
Chief Financial Officer
Sell
4,266
$27.76
$118.43K
Brian Lian
3 Jul 2025
President & CEO
Sell
26,889
$27.80
$747.63K
Greg Zante
6 Jan 2025
Chief Financial Officer
Sell
4,700
$43.32
$203.60K
Greg Zante
6 Jan 2025
Chief Financial Officer
Sell
45,609
$42.69
$1.95M
Marianna Mancini
6 Jan 2025
Chief Operating Officer
Sell
5,100
$43.32
$220.91K
Marianna Mancini
6 Jan 2025
Chief Operating Officer
Sell
49,115
$42.69
$2.10M
Brian Lian
6 Jan 2025
President & CEO
Sell
19,000
$43.32
$823.02K
Brian Lian
6 Jan 2025
President & CEO
Sell
175,490
$42.68
$7.49M
Marianna Mancini
30 Jul 2024
Chief Operating Officer
Sell
3,322
$57.82
$192.08K
Marianna Mancini
30 Jul 2024
Chief Operating Officer
Sell
14,704
$56.98
$837.83K
Brian Lian
30 Jul 2024
President & CEO
Sell
30,417
$58.78
$1.79M
Brian Lian
30 Jul 2024
President & CEO
Sell
19,501
$57.81
$1.13M
Brian Lian
30 Jul 2024
President & CEO
Sell
65,941
$56.95
$3.76M
Greg Zante
30 Jul 2024
Chief Financial Officer
Sell
500
$58.71
$29.36K
Greg Zante
30 Jul 2024
Chief Financial Officer
Sell
2,974
$57.71
$171.63K
Greg Zante
30 Jul 2024
Chief Financial Officer
Sell
12,662
$56.96
$721.23K
Greg Zante
4 Jan 2024
Chief Financial Officer
Sell
15,000
$17.90
$268.50K
Brian Lian
1 May 2023
President & CEO
Sell
45,000
$22.45
$1.01M
Brian Lian
19 Apr 2023
President & CEO
Sell
35,000
$21.45
$750.75K
Brian Lian
3 Apr 2023
President & CEO
Sell
22,000
$17.85
$392.70K
Ligand Pharmaceuticals Inc
26 Aug 2020
10% owner
Sell
94,488
$8.11
$766.11K
Ligand Pharmaceuticals Inc
25 Aug 2020
10% owner
Sell
70,000
$8.02
$561.58K
Matthew W Foehr
30 Jun 2020
Director
Sell
13,000
$7.35
$95.55K
Ligand Pharmaceuticals Inc
25 Sep 2018
10% owner
Sell
262,881
$19.15
$5.03M
Michael Morneau
31 May 2018
VP, Finance and Administration
Sell
21,551
$9.25
$199.35K
Show all 125 transactions →

What was left out

Form 4 filings counted 173
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 66
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 8,612,884
Sales filed before the plan box existed 5
History held since 30 Apr 2015